文献速递青光眼小儿眼科与斜弱视

Trab360 装置行内路小梁切开术治疗儿童青光眼

Trabeculotomy Ab Interno With the Trab360 Device for Childhood Glaucomas.
PubMed 文献 · Am J Ophthalmol · 2019-10-21

多中心回顾性介入病例系列纳入41例(46眼)儿童青光眼患者,使用Trab360装置行内路小梁切开术,平均治疗290°。中位随访14.5个月,手术成功率67.4%(95%CI 51.9%-80.0%),原发性先天性青光眼成功率81%,2眼(4.3%)发生睫状体分离。

要点

  • Trab360内路小梁切开术治疗儿童青光眼总体成功率为67.4%(95%CI 51.9%-80.0%)。
  • 原发性先天性青光眼成功率81%(95%CI 57.4%-93.7%),首次青光眼手术者成功率83.3%(95%CI 57.7%-95.6%)。
  • 2眼(4.3%)发生睫状体分离,无其他显著并发症。

核心结论

  • Trab360的成功率与其他儿童青光眼角部手术的文献报道相似。
  • 良好的手术技术和在高风险房角中保持谨慎对于避免睫状体分离至关重要。
  • 单切口内路小梁切开术使用Trab360装置治疗儿童青光眼有效且安全,尤其是原发性先天性青光眼。

研究设计与样本

  • 多中心回顾性介入病例系列,纳入41例患者共46眼儿童青光眼,接受Trab360内路小梁切开术且随访至少3个月。
  • 手术时中位年龄12个月(范围1-325个月,平均71个月),54%在20个月前手术;48%为右眼,48%为男性。
  • 平均治疗290°;中位随访14.5个月(范围6-34个月,平均16.2个月)。

主要发现

  • 术前中位眼压30 mm Hg(范围18-49 mm Hg,平均30.9 mm Hg),术后中位眼压18 mm Hg(范围5-40 mm Hg,平均20.3 mm Hg)。
  • 术前中位青光眼药物数量2.5种(范围0-5,平均2.6),术后中位1种(范围0-4,平均1.6)。
  • 总体成功率为67.4%(95%CI 51.9%-80.0%);Trab360作为首次青光眼手术的40眼中成功率为70%(95%CI 53.3%-82.9%)。
  • 原发性先天性青光眼成功率为81%(95%CI 57.4%-93.7%);其中Trab360作为首次青光眼手术的18眼成功率为83.3%(95%CI 57.7%-95.6%)。
  • 2眼(4.3%)发生睫状体分离,无其他显著并发症。

关键数值与推荐

  • 手术成功定义为术后眼压小于或等于24 mm Hg,伴或不伴使用药物,且无需额外手术。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 本研究受限于任何回顾性分析固有的不完美之处。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To report outcomes and complications of trabeculotomy ab interno using the Trab360 device (Trab360; Sight Sciences, Menlo Park, California, USA) in eyes with childhood glaucomas. DESIGN: Multicenter retrospective interventional case series. METHODS: Eyes with childhood glaucomas that underwent Trab360 with at least 3 months follow-up were evaluated. Postoperative intraocular pressure (IOP) less than or equal to 24 mm Hg with or without medications and no additional surgery defined success. RESULTS: Forty-six eyes of 41 patients were included. Median age at surgery was 12 months (range 1-325 months, mean 71 months); 54% prior to 20 months. A total of 48% were right eyes; 48% were male. Mean treatment was 290°. Median follow-up was 14.5 months (range 6-34 months, mean 16.2 months). Median preoperative IOP was 30 mm Hg (range 18-49 mm Hg, mean 30.9 mm Hg); median postoperative IOP was 18 mm Hg (range 5-40 mm Hg, mean 20.3 mm Hg]. Median number of preoperative glaucoma medications was 2.5 (range 0-5, mean 2.6); median number postoperatively was 1 (range 0-4, mean 1.6). Success was achieved in 67.4% (95% CI: 51.9%-80.0%) of eyes. Among 40 eyes for which Trab360 was the first glaucoma surgery, success rate was 70% (95% CI 53.3%-82.9%). Success was achieved in 81% (95% CI 57.4%-93.7%) of primary congenital glaucoma (PCG) eyes. Among 18 PCG eyes for which Trab360 was the first glaucoma surgery, success rate was 83.3% (95% CI 57.7%-95.6%). Two eyes (4.3%) suffered cyclodialysis. There were no other significant complications. CONCLUSIONS: Trab360 success resembles literature on other angle surgeries for childhood glaucomas. Good surgical technique and caution in high-risk angles is imperative to avoid cyclodialysis. Our study is limited by the imperfections inherent in any retrospective analysis. Single-incision ab interno trabeculotomy with the Trab360 device is effective and safe for treating childhood glaucomas, especially PCG.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Areaux RG, Grajewski AL, Balasubramaniam S, et al. Trabeculotomy Ab Interno With the Trab360 Device for Childhood Glaucomas. Am J Ophthalmol. 2019. PMID: 31647927. doi:10.1016/j.ajo.2019.10.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。